Vivian Lopez-Blanco is CFO at MEDNAX, INC. (MD). They have made 5 open-market trades across 1 company since 2010, most recently 2023-12-31.
CIK 0001479017
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 5 sales. Too few scored purchases to measure a record yet.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| MD | SELL | 2018-06-12 | 2018-06-13 | $46.46 | $1.3M | -5.3% | -5.1% | +1.6% |
| MD | SELL | 2017-05-05 | 2017-05-08 | $55.82 | $868K | +2.6% | +0.3% | -18.7% |
| MD | SELL | 2017-02-17 | 2017-02-17 | $70.01 | $2.1M | +1.4% | +0.0% | -20.9% |
| MD | SELL | 2017-01-17 | 2017-01-17 | $70.95 | $710K | -3.0% | -1.3% | -3.8% |
| MD | SELL | 2016-05-02 | 2016-05-02 | $71.22 | $666K | -1.2% | -2.2% | -0.8% |
| MD | SELL · 10b5-1 | 2015-07-31 | 2015-07-31 | $83.45 | $835K | -6.0% | +0.7% | +0.7% |
| MD | SELL · 10b5-1 | 2015-02-06 | 2015-02-06 | $69.95 | $577K | -6.0% | +0.7% | +0.7% |
| MD | SELL · 10b5-1 | 2014-10-30 | 2014-10-31 | $60.00 | $528K | -6.0% | +0.7% | +0.7% |
| MD | SELL · 10b5-1 | 2014-02-03 | 2014-02-05 | $55.20 | $508K | -6.0% | +0.7% | +0.7% |
| MD | SELL · 10b5-1 | 2013-04-02 | 2013-04-03 | $90.00 | $315K | -6.0% | +0.7% | +0.7% |
| MD | SELL · 10b5-1 | 2012-12-04 | 2012-12-06 | $80.00 | $296K | -6.0% | +0.7% | +0.7% |
| MD | SELL · 10b5-1 | 2012-02-16 | 2012-02-17 | $75.00 | $338K | -6.0% | +0.7% | +0.7% |
| MD | SELL · 10b5-1 | 2011-06-02 | 2011-06-03 | $74.56 | $35K | -6.0% | +0.7% | +0.7% |
| MD | SELL · 10b5-1 | 2011-05-04 | 2011-05-05 | $72.00 | $133K | -6.0% | +0.7% | +0.7% |
| MD | SELL · 10b5-1 | 2010-11-04 | 2010-11-05 | $61.50 | $114K | -6.0% | +0.7% | +0.7% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.